The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Metformin and cytokine release syndrome after immune effector cell therapy.
 
Aytaj Mammadzadeh
No Relationships to Disclose
 
Radhika Bansal
No Relationships to Disclose
 
Hassan B. Alkhateeb
No Relationships to Disclose
 
Stephen M. Ansell
Honoraria - Answers in CME; Medscape; Research to Practice; WebMD
Research Funding - ADC Therapeutics (Inst); Affimed Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Pfizer (Inst); Regeneron (Inst); Seagen (Inst); Step Pharma (Inst); Takeda (Inst)
 
Nabila Nora Bennani
Consulting or Advisory Role - Acrotech Biopharma (Inst); Affimed Therapeutics (Inst); Astellas Pharma (Inst)
Research Funding - Vyriad (Inst)
 
Moritz Binder
No Relationships to Disclose
 
Joselle Cook
Stock and Other Ownership Interests - Geron
 
Urshila Durani
No Relationships to Disclose
 
Morie A. Gertz
No Relationships to Disclose
 
Paul Joseph Hampel
No Relationships to Disclose
 
Suzanne R. Hayman
No Relationships to Disclose
 
Patrick B. Johnston
No Relationships to Disclose
 
Prashant Kapoor
Honoraria - Abbvie (Inst); Abbvie (Inst); AstraZeneca; BeiGene; MustangBio; Pharmacyclics; Sanofi (Inst)
Consulting or Advisory Role - Sanofi (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); GlaxoSmithKline (Inst); Ichnos Sciences (Inst); Karyopharm Therapeutics (Inst); Regeneron (Inst); Sanofi (Inst); Sorrento Therapeutics (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Janssen; Sanofi
 
Saad Kenderian
No Relationships to Disclose
 
Arushi Khurana
No Relationships to Disclose
 
Shaji Kumar
Consulting or Advisory Role - Abbvie (Inst); Bristol-Myers Squibb/Celgene (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); K36 (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Allogene Therapeutics (Inst); Bristol-Myers Squibb/Celgene (Inst); CARsgen Therapeutics (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); MedImmune (Inst); Novartis (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Pfizer
 
Taxiarchis Kourelis
Research Funding - Novartis
 
Yi Lin
Consulting or Advisory Role - Adicet Bio (Inst); Bristol-Myers Squibb (Inst); Caribou Biosciences (Inst); Chimeric Therapeutics (Inst); Fosun Kite (Inst); Genentech (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Nektar (Inst); NexImmune (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Vineti (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Janssen Oncology (Inst)
 
Jonas Paludo
Consulting or Advisory Role - Abbvie (Inst)
Research Funding - Biofourmis (Inst); Karyopharm Therapeutics (Inst)
 
David Dingli
Honoraria - Alexion Pharmaceuticals; Apellis Pharmaceuticals; BMS Brazil; JJ Innovative Medicine; Merck Sharp & Dohme; Novartis; Sanofi; Sorrento Therapeutics
Research Funding - K36